Considering the poor intrinsic healing potential of articular cartilage, resident chondrogenic stem/progenitor cells (CSPCs) have gained attention in recent years. Although, CSPCs are attracted by a cartilage injury, knowledge about the post-traumatic behaviour and functional role of this cell population is fairly basic. The present study, not only elaborated on the regenerative capacities of CSPCs, but also illuminated potential immunomodulatory properties after cartilage trauma.
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Introduction
Articular cartilage is an avascular tissue with little healing capacity. Consequently, injuries of the cartilage or the adjacent soft tissue represent a crucial risk factor for progressive cartilage degeneration and development of a PTOA (Whittaker et al., 2015) . Even a single traumatic impact can initiate a chain reaction of pathomechanisms, characterised by ongoing cell death and degradation of the ECM driven by cytokines and ROS (Henrotin et al., 2005) . Considering the high prevalence of arthritic joint diseases and the inefficacy of current therapeutic options, novel approaches providing not only symptomatic relief, but also support of the intrinsic regeneration are needed. Besides pharmacologic treatment, cell-based therapy has increasingly gained importance. In this context, immunomodulatory properties of BM-MSCs and their possible application in arthritic diseases are described (van Buul et al., 2012) . A migratory cartilage-resident cell population, also referred to as CSPCs, has gained attention due to its beneficial localisation and innate chondrogenic phenotype, reflected in superior chondrogenic differentiation capacities as compared to BM-MSCs (Jiang and Tuan, 2015; Xue et al., 2016) . Moreover, CSPCs possess multipotent differentiation capacities and a surface marker expression profile similar to that of BM-MSCs, including the minimal criteria, commonly used to identify MSCs (Dominici et al., 2006; Joos et al., 2013) . This makes CSPCs a promising target to improve intrinsic healing of cartilage defects but also in terms of tissue engineering (Elsaesser et al., 2016; Jiang and Tuan, 2015) . CSPCs are attracted by DAMPs, such as HMGB1 (Seol et al., 2012) , and signalling molecules, comprising SDF-1 (Yu et al., 2015) , IGF-1 and PDGF (Joos et al., 2013) . In contrast, OA-associated cytokines IL-1ß and TNF-α significantly inhibit the migration of CSPCs towards TC medium (Joos et al., 2013) . CSPCs might also contribute to the clearance of cell and matrix debris, such as Fn-fs, which are generated after mechanical impact, and trigger detrimental chondrolysis (Ding et al., 2014; Zhou et al., 2016) . Moreover, comprehensive microarray analysis of CSPCs reveals high expression levels of PRG4, a disease-modifying and surface-protective lubricant, implying further chondro-protective properties of the cell population (Flannery et al., 2009; Seol et al., 2012) .
CSPCs express significantly higher levels of inflammation-associated genes, such as IL-6 and -8, as compared to chondrocytes (Seol et al., 2012; Zhou et al., 2014) , although CSPC-mediated contribution to the inflammatory response after trauma is not confirmed so far. Since DAMPs, in particular HMGB1 and S100A8/9, induce pro-inflammatory response by signalling through PRRs, namely TLR4 and RAGE (Bertheloot and Latz, 2017) , the current study's working hypothesis was that DAMPs not only trigger chemotaxis but might also elicit an immunomodulatory response in CSPCs. To elucidate this issue, isolated CSPCs were stimulated with culture medium obtained from impacted cartilage explants and the expression of relevant key mediators involved in immunomodulation was evaluated. Moreover, classic in vitro wound healing, proliferation, chemotaxis and chondrogenic differentiation assays were included to examine the impact of trauma-related factors on CSPC regenerative capacities.
As a second objective, the study extended its focus from the post-traumatic role and behaviour of CSPCs to the possibility of influencing this response by using antioxidative and chondroanabolic therapeutics, such as NAC (Riegger et al., 2016) , FGF18, BMP7 and IGF-1 (Riegger et al., 2017) .
Materials and Methods
Preparation and cultivation of human cartilage explants Human cartilage was obtained from donors undergoing total knee joint replacement due to OA. Informed consent was obtained from all patients
Post-traumatic response of CSPCs according to the terms of the ethics committee of the University of Ulm, Germany. Only macroscopically intact tissue samples (International Cartilage Repair Society score ≤ 1) (Kleemann et al., 2005) from femoral condyles were included in the study. Full-thickness cartilage explants (6 mm in diameter) were cultivated in serum-containing chondrocyte medium [1 : 1 DMEM/Ham's F12, 10 % foetal bovine serum, 0.5 % penicillin/streptomycin (PAA Laboratories), 0.5 % L-glutamine and 10 μg/mL 2-phospho-L-ascorbic acid trisodium salt (Sigma-Aldrich)] at 37 °C, 5 % CO 2 and 95 % humidity until traumatisation on the following day. Afterwards, the explants were cultivated for up to 14 d in serum-free medium [DMEM, 1 % sodium pyruvate, 0.5 % L-glutamine, 1 % non-essential amino acids, 0.5 % penicillin/streptomycin and 0.1 % ITS (Sigma-Aldrich)]. All medium components were purchased from Biochrom (Berlin, Germany) unless specified otherwise.
Impact loading and subsequent treatment
Cartilage explants from tissue of 8 patients (mean age 64, range 54-74 years) were subjected to a defined impact energy of 0.59 J by using a drop-tower model, as previously described (Riegger et al., 2016) . Impacted cartilage explants were incubated with and without therapeutic additives: 100 ng/mL rhIGF-1 (= IGF-1), 200 ng/mL rhFGF18 (= FGF18), 100 ng/mL rhBMP7 (= BMP7) (Peprotech) or 2 mM NAC (Sigma-Aldrich). Fresh additives were provided concomitantly with medium change every 2-3 d. The concentrations of the therapeutics were selected based on previous studies (Riegger et al., 2016; Riegger et al., 2017) .
Isolation and cultivation of CSPCs and chondrocytes
Cells were isolated from human cartilage (see above) of 18 patients (mean age 67, range 50-80 years), according to Koelling et al. (2009) . In short, thin cartilage slices were prepared from macroscopically intact tissue regions of the femoral condyles and placed in a 6-well culture dish with basal medium (DMEM, 10 % FCS, 1 % penicillin/streptomycin, 1 % L-glutamine). A cell strainer (BD GmbH) was used to keep cartilage slices down on the well bottom. After outgrowth from cartilage tissue, CSPCs were split at a confluence of 80 % and used at passage 3 to 4. Chondrocytes were isolated from human cartilage of 4 patients (mean age 69, range 61-80 years) by enzymatic digestion. In short, full-thickness cartilage was minced and digested for 45 min with 0.2 % pronase (Sigma-Aldrich) and overnight with 0.025 % collagenase (Sigma-Aldrich). After washing with PBS and filtration through a 40 μm cell strainer (BD GmbH), cells (passage 0) were cultured in serum-containing chondrocyte medium (see above). Chondrocytes were split at a confluence of 80 % and used at passage 1.
Flow cytometry analysis
To estimate the number of cells carrying CSPCassociated surface markers within the cartilage 14 d after trauma, cells were released from the ECM by enzymatic digestion using the method described in the previous section for chondrocyte isolation. Unimpacted explants served as controls. To obtain adequate numbers of cells, 4 to 5 punches were used for each condition (control, trauma with and without treatment). Isolated cells were immunocytologically stained on ice, for 30 min in the dark, with antibodies against CSPC-associated surface markers, CD45 and species-matched isotype controls, respectively. CD9, CD45, CD73, CD166 and IgG1κ were obtained from BD Bioscience (Heidelberg, Germany), CD105, Stro-1, MSCA-1 and IgM λ from BioLegend (Fell, Germany), IgG2a and IgG1 from R&D Systems (Minneapolis, MN, USA) and CD90 from eBioscience (Frankfurt, Germany). Compositions of the panels and fluorescent labelling of the antibodies are listed in mL penicillin/streptomycin, 40 ng/mL L-proline, 0,1 µmol/L dexamethasone, 50 µg/mL ascorbic acid, 10 μL/mL ITS (Sigma-Aldrich), 10 ng/mL rhTGF-β3 (= TGF-β3; R&D Systems) and 10 ng/mL rhBMP6 (= BMP6; Peprotech)]. During the first week, TGF-β3 and BMP6 were freshly added every day; afterwards -similarly to NAC (2 mM) and/or IGF-1 (100 ng/mL), FGF18 (200 ng/mL) or BMP7 (100 ng/ mL) -concomitantly with medium change every 2-3 d. For the IHC, 3.5 μm-thick paraffin-embedded sections were dewaxed, rehydrated and pre-digested for 30 min at 37 °C for antigen retrieval with pepsin (1 mg/mL in 0.5 M acetic acid), in case of collagen II staining, or with hyaluronidase (2 mg/mL in sodium
Post-traumatic response of CSPCs acetate pH 5), in case of COMP staining. Sections were treated with 3 % hydrogen peroxide before starting the staining with the Dako LSAB2 System-HRP kit (Dako) and antibodies against collagen II (AF5710; Acris, Hiddenhausen, Germany) or COMP (provided by F. Zaucke, Frankfurt, Germany). For histological staining of proteoglycans, safranin O (Fisher Scientific) was used. In all samples, a final staining of cell nuclei by Gill's haematoxylin No 3 (Sigma-Aldrich) was performed. To evaluate chondrogenic differentiation, the Bern scoring was extended by further categories to an appropriately designed scoring system as itemised in Table 2 ( Grogan et al., 2006) .
Stimulation of isolated cartilage cells
Conditioned medium was collected 24 h or 7 d (last medium change 48 h before) after trauma from unimpacted or impacted human cartilage tissue incubated with and without therapeutic additives in 1 mL per well of serum-free medium in a 24-well plate (one cartilage explant per well). In the case of the CC medium used for the chondrogenic differentiation, explants were cultivated in CDM accordingly. CSPCs/ chondrocytes were seeded on 48-well cell culture plates (0.5 × 10 5 cells/cm 2 ) and incubated in serumcontaining medium for 6 h to adhere. Afterwards, complete medium was discarded and replaced by serum-free medium for adaptation. The next day, isolated CSPCs/chondrocytes were stimulated for 48 h by conditioned medium, mixed 1 : 1 with serumfree medium to a total volume of 300 µL. To consider the sole influence of the therapeutic intervention, the therapeutics were retrospectively added to CSPCs stimulated with TC medium or directly added to unstimulated CSPCs. The different approaches and corresponding abbreviations are listed in Table 3 .
Gene expression analysis
Total RNA isolation of cell lysates by means of the RNA Mini Kit and subsequent reverse transcription by means of the Omniscript RT Kit were performed in accordance with the manufacturer's instructions (QIAGEN).
Relative gene expression levels of the target genes were determined by quantitative real-time polymerase chain reaction (qRT-PCR), using the 2 -ΔΔCt method and the StepOnePlus™ Real-Time PCR System (Applied Biosystems). Target sequences were detected using the TaqMan ® Gene Expression Master Mix and the following TaqMan ® Gene Expression Assays (both Applied Biosystems): TSG6 (TNFAI P6), HS01113602; CXCL1 (Gro-α), HS00605382; IL-8 (CXCL8), HS00174103; IL-1ß, HS00174097; RAGE (AGER), HS005422584; TLR4, HS00152939; IL-10, HS00961622; TNF-α, HS1113624.
In case of the endogenous controls, Power SYBR™ Green PCR Master Mix (Applied Biosystems) was used for the 18S rRNA, with the 5'-CGCAGCTAGGAATAATGGAATAGG-3' (forward) and 5'-CATGGCCTCAGTTCCGAAA-3' (reverse) primers and Platinum™ SYBR™ Green qPCR SuperMix-UDG (Invitrogen) was used for GAPDH, with the 5'-TGGTATCGTGGAAGGACTCATG-3' (forward) and 5'-TCTTCTGGGTGGCAGTGATG-3' (reverse) primers. Target mRNA-expression was normalised to the endogenous controls.
alamarBlue
® proliferation assay Quantitative measurement of cell proliferation was attained by means of an alamarBlue ® assay (BioRad). The conversion of non-fluorescent resazurin to fluorescent resorufin by FMNH 2 , FADH 2 , NADH, NADPH and cytochromes, released during cellular respiration, is proportional to the number of living cells. After 48 h, wells were rinsed with PBS and cells were incubated for 4 h at 37 °C in 200 µL of a 5 % alamarBlue ® solution (in serum-free medium). After the incubation period, the fluorescence intensities were detected at 550 nm excitation and 590 nm emission by using the multimode microplate reader Infinite M200 Pro (Tecan Austria GmbH, Groedig, Austria). Blank values (5 % alamarBlue ® solution in empty well) were subtracted from measured values.
In vitro wound healing/scratch assay CSPCs were grown to a confluent monolayer on 24-well culture plates. After creating a scratch in the cell layer with a 200 μL pipette tip, cell debris were removed by rinsing with PBS. Cells were cultivated in basal medium mixed 1 : 1 with serum-free TC medium, with 5 % FCS. The closure of the scratch was documented by phase contrast microscopy after 24 h and 48 h and was quantified by counting the cells present in the initial gap.
Chemotaxis/Boyden chamber assay Directed cell migration was analysed by a modified Boyden chamber assay, using a 48-well microchemotaxis chamber and polycarbonate filters (8 μm pores; both: NeuroProbe Inc., Baltimore, MD, USA), as previously described (Fiedler et al., 2006) . TC medium was diluted in DMEM (1 : 1), filled into the lower compartment of the chemotaxis chamber and covered with the chemotaxis filter. The upper wells were loaded with 50 μL cell suspension in DMEM (1 × 10 4 cells) and incubated for 4 h at 37 °C, 5 % CO 2 in 95 % humidity. DMEM in the lower well served as a negative control (basal migration). The filter was removed, washed with PBS and non-migrated cells on the upper side of the filter were removed using a cell scraper. The migrated cells on the lower side were fixed with 4 % formaldehyde, stained with Giemsa solution (Merck) and counted (n = 4 technical replicates).
Statistical analysis
Statistical analysis of results from at least three independent experiments (biological replicates) was performed using GraphPad Prism version 6.0h. Data sets with n ≥ 5 were tested for outliers with the Grubbs outlier test. Outliers were not included in the www.ecmjournal.org statistical analysis. The applied statistic method can be found in the caption of the corresponding figures. Significant level was set to p = 0.05.
Results
Regenerative potentials of CSPCs after cartilage trauma MSC-related surface markers CD9, CD105, CD166 and MSCA-1 were significantly enhanced after cartilage trauma To estimate the influence of trauma and subsequent treatment on the CSPC population within the corresponding cartilage explants, whole cell isolation was achieved by enzymatic digestion 14 d post trauma. The histogram of the isolated cells' data noticeably shifted in the impacted cartilage explants (red curve, Fig. 1a-h ) as compared to the unimpacted cartilage explants (green curve, Fig. 1a-h ). In fact, isolated cartilage cells from impacted tissue exhibited a significantly higher incidence of CD9-(3.4-fold, p = 0.015), CD105-(1.5-fold, p = 0.008), CD166-(2.4-fold, p = 0.042) and MSCA-1-(1.9-fold, p = 0.045) positive cells (Fig. 1i) . Treatment of impacted cartilage explants with FGF18 resulted in a significant increase in CD166 + cells as compared to untreated tissue (2.3-fold, p = 0.008) (Fig. 1j) . (Fig.  2a,b) , which comprises undirected migration and proliferative activity (Jonkman et al., 2014) . Directed migration (towards a chemotactic gradient) and proliferation of the CSPCs were additionally quantified by Boyden chamber assay (Fig. 2c) and alamarBlue ® assay (Fig. 2d) , respectively. After 24 h, TC-medium-stimulated CSPCs exhibited significant closure of the artificially applied scratch lesion (p < 0.0001 vs. basal; p = 0.0009 vs. unimpacted; . 2b) , which was comparatively lower in TNC-(p = 0.0073) or TBC-stimulated cells (p = 0.0428). After 48 h, the gap of TC-stimulated CSPCs was highly repopulated (p < 0.0001 vs. basal and unimpacted). This effect was significantly lower after stimulation with any treated cartilage culture medium (TNC and TFC: p = 0.0004; TIC: p = 0.0003; TBC: p < 0.0001, all vs. TC medium).
In comparison to unstimulated CSPCs, cell proliferation was significantly enhanced 48 h after stimulation with TC medium (p = 0.001), TIC (p = 0.0039), TFC (p = 0.0024) and TBC (p = 0.0017) by around 2.7-fold each (Fig. 2a) . Stimulation with CC medium or TNC had no significant influence on the mitotic activity, although, traumaassociated enhancement of cell proliferation was significantly lower in TNC-stimulated CSPCs (− 1.7-fold vs. TC, p = 0.0387). Additional Boyden chamber analysis revealed that chemotaxis of CSPCs was not significantly enhanced by CC medium, but by all media obtained from traumatised cartilage regardless of the subsequent treatment: vs. basal, TC medium: p = 0.0001, TNC and TIC: p < 0.0001, TFC and TBC: p = 0.0002; vs. CC medium, TC: p = 0.0128, TNC:
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Chondrogenic differentiation of CSPCs was suppressed by TC, NAC or FGF18 simulation but improved by IGF-1 or BMP7
Additional co-stimulation of CDM-stimulated CSPCs influenced chondrogenic differentiation in different ways, as demonstrated by chondrogenic marker staining intensities (Fig. 3a) , pellet size, ECM formation and cell proliferation (Dexheimer et al., 2012) (Fig. 3d-f ). Histological assessment (Fig. 3b,c and Table 4 ) revealed that additional stimulation with the chondroanabolic IGF-1 and BMP7 enhanced the type II collagen biosynthesis as compared to CDM (Table 4 ; BMP7: p = 0.0115, IGF-1: p = 0.0709). In contrast, chondrogenic markers were significantly decreased after addition of NAC and FGF18, as reflected in the overall score (p < 0.0001 each vs. CDM, BMP7 and IGF-1; Fig. 3b ). Attempts to counterbalance NAC-mediated suppression of the chondrogenic differentiation by simultaneous stimulation with IGF-1, FGF18 or BMP7 failed (Fig. 3b) . However, after depriving NAC on day 8, chondrogenic characteristics recovered partially (NAC− vs. NAC, p = 0.0683), as observed 21 d after deprivation of NAC.
Additional stimulation with IGF-1 or BMP7 further improved the differentiation after deprivation of the antioxidant (NAC− vs. NAC−/IGF-1 p = 0.0034; NAC− vs. NAC−/BMP7, p < 0.0001). Co-stimulation with CC-CDM had no significant effect on the chondrogenic differentiation of CSPCs, although, addition of TC-CDM significantly decreased the overall score ( Fig. 3c ; TC vs. CDM, p < 0.0001). This trauma-mediated impairment of the chondrogenic differentiation could partly be compensated by BMP7-treatment of impacted cartilage explants, as demonstrated by co-stimulation with TBC-CDM (overall score TBC vs. TC: p < 0.0001).
Immunomodulatory potentials of CSPCs after cartilage trauma Gene expression of immunomodulatory mediators was enhanced in TC-medium-stimulated CSPCs, although it could be attenuated by immediate therapeutic intervention
To investigate a possible immunomodulatory response of CSPCs affecting both injury-associated factors and therapeutic intervention, relative gene expression levels of chemokines IL-8 and CXCL1 (Fig. 4a-c) , pro-inflammatory cytokines TNF-α and IL-1ß (Fig. 4d-f) , anti-inflammatory mediators IL-10 and TSG-6 (Fig. 4g-i) and PRRs RAGE and TLR4 (Fig.  4j-l) were evaluated 48 h after CSPC stimulation with differently conditioned media (Table 3) .
TC medium stimulation significantly increased the gene expression of IL-8 (2.7-fold, p = 0.0009), CXCL1 (2-fold, p = 0.0009), IL-10 (2-fold, p = 0.0072), TSG6 (1.5-fold, p = 0.0397), TLR4 (2-fold, p = 0.0175) and RAGE (2.3-fold, p = 0.0002) as compared to the corresponding gene expression in CC-medium-stimulated CSPCs (Fig. 4a,d,g,j) . IL-1ß was not consistently expressed in CSPCs, unless cells were stimulated with TC medium (about 15-fold enhanced). Stimulation with media obtained from treated cartilage explants did not induce the expression of the analysed genes, except for TLR4, which was only alleviated by BMP7 and enhanced by FGF18 (significant differences between TC medium and TNC/TIC/TFC/TBC are given in Table 5 ). Overall, gene expression of TNF-α was generally low (> 40 cycles) and could not be detected reliably.
However, gene expression of TC-mediumstimulated CSPCs was differentially influenced by costimulation with the therapeutics (Fig. 4b,e,h,k) . IGF-www.ecmjournal.org Comparable effects of the therapeutics were found in CSPCs cultivated in basal medium (Fig.  4c,f, Additional gene expression analysis of CC-and TC-medium-stimulated chondrocytes (Fig. 4m) , which served as comparative group, revealed a partially significant response regarding the mRNA expression of IL-8 (CC: 2.6-fold, p = 0.0006; TC: 2-fold, p = 0.0885; both vs. basal) and CXCL1 (CC: 2.1-fold, p = 0.0067; TC: 2.1-fold, p = 0.0096; both vs. basal). However, in contrast to CSPCs, no significant difference between CC-and TC-medium stimulation was observed.
IL-6 release was enhanced in TC-medium-stimulated CSPCs, although suppressed by immediate therapeutic intervention
To further elucidate the immunomodulatory response of CSPCs after trauma and the possible influence of therapeutic additives, the release of IL-6 was quantified by ELISA (Fig. 5a-c) .
The presence of IL-6 within the CC medium was evaluated beforehand and could not be confirmed. CSPC stimulation with CC medium significantly enhanced IL-6 release as compared to unstimulated CSPCs cultivated in unconditioned medium (basal) ( Fig. 5a ; CC: 5.5-fold; TC: 31.2-fold, p < 0.0001; TNC: 14.5-fold, p = 0.008; TIC: 13.8-fold, p = 0.0095; TFC: 8.3-fold, TBC: 9.2-fold). IL-6 release of TCmedium-stimulated CSPCs was significantly higher than CC-medium-stimulated CSPCs (5.7-fold, p < 0.0001). Medium of treated cartilage explants had significantly less effect on IL-6 secretion as compared to TC medium (TNC: − 2.2-fold, p = 0.0003; TIC: − 2.3-fold, TFC: − 3.7-fold, TBC: − 3.4-fold; all others: p < 0.0001).
Retrospective addition of FGF18 potentiated the TC-medium-induced release of IL-6 (TFC: 1.5-fold, p = 0.026), while BMP7 and IGF-1 had significant alleviating effects (TC + IFGF1: − 3.4-fold, p < 0.0001; TC + BMP7: − 2.8-fold, p = 0.0002) (Fig. 5b) .
Stimulation with CC medium collected at day 7 had a reduced influence on IL-6 release ( Fig. 5c ; TC: p < 0.0001; TIC: p = 0.0188; 7 d vs. 24 h). Nevertheless, TC medium stimulation increased IL-6 release by 20.8-fold and 5.2-fold (both p < 0.0001), compared to unstimulated and CC-medium-stimulated CSPCs, respectively. Stimulation with medium obtained from treated cartilage explants resulted in attenuated IL-6 release (TC + NAC: − 1.8-fold, p = 0.0484; TC + IFGF1: − 1.9-fold, p = 0.0243; TC + FGF18: − 2.8-fold, p = 0.0012; TC + BMP7: − 2.1-fold, p = 0.0122; all vs. TC).
Discussion
Although microarray analysis indicated that CSPCs may play a crucial role in pro-inflammatory response after cartilage injury (Zhou et al., 2014) , conclusive scientific data confirming this presumption are lacking. In consideration of the known similarities between CSPCs and MSCs, the working hypothesis of this study was that CSPCs might possess MSClike immunomodulatory competences rather than solely pro-inflammatory ones. In fact, TC TC-and TNC-, TIC-, TFC-, TBC-stimulation on CSPC gene expression. Effects of CSPC stimulation with TNC, TIC, TFC or TBC on immunomodulation-associated gene expression after 48 h. Results were compared to CSPCs exposed to medium obtained from impacted, untreated cartilage explants (TC). Statistical analysis was performed by means of a Student's t-test. n.d. = not detected. medium stimulation of isolated CSPCs significantly enhanced the gene expression of pro-inflammatory but also anti-inflammatory mediators, which was not the case in equivalently treated chondrocytes. Moreover, exposure to trauma-associated factors resulted in a kinetic response including not only accelerated cell proliferation, improved in vitro wound healing capacities and directed migration but also suppressed chondrogenic differentiation. In addition, antioxidative or chondroanabolic therapeutic interventions had diverse influence on the post-traumatic response, depending on whether the therapeutics were applied immediately after trauma or were retrospectively added to the TC medium. Previous studies describe an augmented percentage of CD105 + /166 + cells (Bosserhoff et al., 2014; Grogan et al., 2009) as well as an increased cell cluster formation by Notch-1-, STRO-1-and VCAM-1-expressing cells (Lotz et al., 2010) within an OAaffected tissue. In accordance with these findings, higher incidence of MSC marker-positive cells were found within cartilage explants after ex vivo trauma. This might be related to the enhanced migratory and mitotic activity of TC-medium-stimulated CSPCs, as seen in other studies (Joos et al., 2013; Seol et al., 2012) . To investigate the influence of DAMP release on CSPC proliferation separately from the mechanical impact, in future studies, unimpacted cartilage tissue could be exposed to TC medium, followed by flow cytometric analysis. This might also provide information about influences on the CSPC pool of adjacent uninjured tissue as a possible source for local recruitment of chondrogenic cells.
Cartilage trauma results in an immediate cell death associated with the release of endogenous DAMPs, triggering inflammatory and catabolic response of synovial and cartilage cells (Sokolove and Lepus, 2013) . With regard to PTOA, intracellular alarmins HMGB1 and S100A8/9 play a crucial role in inflammation and degradative processes (Liu-Bryan R, 2010; Schelbergen et al., 2012) . While HMGB1 induces both RAGE and TLR4 signalling (Liu-Bryan R, 2010), S100A8/9 might primarily function through the interaction with TLR4 (Schelbergen et al., 2012) . Exposure of BM-MSCs to DAMPs results in enhanced TLR expression and subsequent transformation of non-immunogenic BM-MSCs into chemotactic immunomodulatory cells, driving the recruitment of immune cells towards the impact site. This process is referred to as TLR-priming (DelaRosa et al., 2012; Najar et al., 2017) . Comparable effects on TLR and RAGE gene expression were observed in TCmedium-stimulated CSPCs, indicating that CSPCs could be equally primed due to trauma-associated conditions.
While the release of intracellular DAMPs peaked 24 h after cartilage trauma and declined afterwards continuously because of decelerated propagation of cell death, ECM-related Fn-fs peak at day 5 (Ding et al., 2014; Wang et al., 2015) . 
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The delayed appearance can be explained by the protease-dependent hydrolysis of Fn into bioactive Fn-fs, which requires MMP-3 and the fibronectinase ADAM8 (Ding et al., 2014; Zack et al., 2009) . Since CSPCs exhibited reduced responsiveness towards TC medium collected 7 d after trauma, it is tempting to speculate that cell-death-related DAMPs might play a major role in activating CSPCs than proteolytically generated ECM-derived factors, also referred to as matricryptins (Labat-Robert, 2003) , do, at least in the present study. Therefore, attenuated responsiveness towards medium from impacted and subsequently treated cartilage explants was hypothesised to rely on cell-protective effects of the therapeutics and consequent prevention of intracellular DAMP release. Although, previous results reveal significant differences in the therapeutic efficacies in terms of initial harm reduction after cartilage, which are particularly pronounced between NAC (strong protection) and IGF-1 (weak protection) (Riegger et al., 2017) , the alleviating effect was virtually similar after TIC, TFC, TBC and TNC stimulation. However, decreased responsiveness towards the medium of treated cartilage explants could not be confirmed in the alamarBlue ® or chemotaxis assay. This might rely on the immediate trauma-induced mechanical release of ECM-derived components, such as uncleaved Fn (440 kDa) (Ding et al., 2014) . Although, native Fn does not trigger catabolic responses (Yasuda and Poole, 2002) , it induces directed migration and proliferation of MSCs and subchondral progenitor cells, indicating an involvement in the recruitment of repair cells towards injury sites (Kalkreuth et al., 2014; Thibault et al., 2007) .
Retrospective addition of the therapeutics to TC-medium-stimulated CSPCs uncovered substantial difference among the individual effects. While BMP7 consistently attenuated the proinflammatory response of CSPCs, both as immediate and retrospective treatment, the efficacy of the other tested therapeutics was largely limited to immediate treatment. DAMP-induced gene expression of CXCL1 and IL-8 was even enhanced by retrospective application of FGF18 or IGF-1, which might be connected to the expression of IL-1ß. Comparable increase of IL-8 and CLCX1, but also IL-1ß, IL-6 and other chemokines, is observed after addition of FGF18 to IL-1ß-stimulated chondrocytes (Sandell et al., 2008) . Ding et al. (2017) demonstrate a synergistic interaction between HMGB1 and IL-1ß and conclude that pro-catabolic effects of certain DAMPs might rely on the co-existence of cytokines or Fn-fs. Indeed, S100A8/9-and HMGB1-induced expression of catabolic enzymes as well as pro-and anti-inflammatory mediators is more pronounced in tissue or isolated cells obtained from OA patients as compared to non-arthritic samples (Dave et al., 2017; Ding et al., 2017; Schelbergen et al., 2012) . Similar synergistic effects can be observed in mechanically injured cartilage additionally stimulated with cytokines (Patwari et al., 2003) . However, it remains unclear which DAMPs finally led to the adverse interaction with the retrospectively added growth factors and how this was prevented by immediate application. Overall, the identification of the key factors that play a pivotal role in triggering distinct CSPC responses after cartilage trauma clearly deserves further investigation, including unbiased screening approaches (e.g. proteomic profiling).
Despite simultaneous expression of antiinflammatory mediators, pro-inflammatory response of TC-stimulated CSPCs might give rise to concerns, in particular with regard to the pleiotropic IL-6, whose role in OA is not clarified (Tsuchida et al., 2012) . However, intra-articular injection of autologous MSCs results in pain relief and decreased joint damage in patients suffering from knee OA, despite -or perhaps precisely because of -the secretion of IL-6 (Lamo-Espinosa et al., 2016; Scheller et al., 2011) . Tsuchida et al. (2012) hypothesis is that synovial IL-6 levels might be enhanced in the course of intrinsic regeneration after injury. In alignment with that, binding to its soluble receptor (sIL-6R) and subsequent activation of the IL-6/STAT-3 pathway is essential for the chondrogenic differentiation of MSCs (Kondo et al., 2015) , whereas the absence of sIL-6R results in opposite effect and maintenance of stem cell characteristics, such as enhanced proliferation and wound healing (Pricola et al., 2009) . Interestingly, IL-6 co-localises with CD166 + cells in human cartilage (presumably CSPCs) (Kondo et al., 2015) . In line with that, a possible link between enhanced percentage of CD166 + cells within impacted cartilage explants, increased IL-6 expression and reduced chondrogenic differentiation in the presence of FGF18 was found in the present study. Whether and to what degree CSPC-derived IL-6 might impact the chondrogenic phenotype of adjacent chondrocytes or contribute to synovitis and immune cell recruitment was not addressed.
IL-1ß and HMGB1 are associated with cytokine release and osteogenic differentiation of MSCs (Feng et al., 2016; Ousema et al., 2012) . Moreover, HMGB1 is actively secreted by hypertrophic chondrocytes during endochondral ossification (Taniguchi et al., 2007) . In this context, IL-8 and CXCL1 promote chondrocyte hypertrophy as a sign of terminal differentiation as well as pathologic calcification during OA (Merz et al., 2003) . Accordingly, enhanced gene expression levels of IL-1ß, IL-8 and CXCL1 and suppression of chondrogenic differentiation in TCmedium-stimulated CSPCs were observed in the present study, with all these effect reduced by BMP7.
Apart from TC-medium-stimulation, chondrogenic differentiation of CSPCs was also suppressed by NAC and FGF18. FGF18 is an essential regulator during the embryonic development of the skeletal system, although, it enhances cell proliferation and differentiation in osteogenesis while having opposite effects in chondrogenesis (Ohbayashi et al., 2002; Shu www.ecmjournal.org et al., 2016) . Accordingly, FGF18-stimulation of CSPCs resulted in enhanced expression levels of IL-8 and CLCX1 and enhanced expression of MMP-13 and type X collagen -hypertrophic markers commonly upregulated during IL8/CXCL-1 driven calcification (Merz et al., 2003) -in unimpacted cartilage explants exposed to FGF18 (Riegger et al., 2017) . Gigout et al. (2017) report chondroanabolic properties of sprifermin (FGF18) by an intermittent regimen in which 100 ng/mL sprifermin is applied for only 1 week or 1 d per week (3 times) over a 4-week culture period in serum-containing medium. In line with the results of the current study, permanent application suppressed chondroanabolic characteristics of 3D-cultured chondrocytes.
NAC-mediated interference of chondrogenic differentiation, which even diminished simultaneous stimulation with IGF-1 or BMP7, was largely dependent on the exposure time point. Addition of NAC during the first week might have stronger impairing effect as compared to its application during the second week (Fig. 3f) . Chondrogenesis proceeds in several stages (Chen et al., 2009) , including cellular condensation, ECM remodelling and matrix construction, regulated by various autocrine and paracrine mediators as well as cell-cell/cell-matrix interaction (Li and Dong, 2016) . Proliferation (Dexheimer et al., 2012) , ROS accumulation and expression of MMPs play a crucial role during the early phases of chondrogenic differentiation (Kim et al., 2010) . Since NAC is an efficient ROS scavenger and inhibitor of proliferation, MMP expression and proteolytic activity (Riegger et al., 2016) , it was concluded that these properties interfere with the chondrogenic differentiation. Nevertheless, withdrawal of NAC after 7 d allowed resumption of the chondrogenic differentiation that was significantly improved by subsequent stimulation with IGF-1 or BMP7.
The findings about the post-traumatic response of CSPCs not only affirmed a contribution to regenerative processes but also provided first evidence for immunomodulatory properties after cartilage injury. Since it was quite ambitious to target the functional role of this small ECM-embedded subpopulation in its natural environment, most of the study objectives were elucidated in isolated CSPCs. Therefore, future studies on the regenerative potentials of CSPCs should be extended to the crosstalk with synovial cells, chondrocytes and cartilage explants.
Conclusions
The present results indicated that CSPCs responded to cartilage injury and the correspondingly released DAMPs by enhanced proliferation, migration and expression of immunomodulatory mediators. Despite increased early wound healing capacities, the chondrogenic differentiation was impaired by trauma-associated factors, indicating a counteraction in the regeneration of cartilage defects. Although, the prevailing effector molecules were not identified, it could be demonstrated that the post-traumatic behaviour of CSPCs could be differentially modified by pharmacologic intervention, whereby BMP7 revealed the most beneficial effects. Overall, prevention of DAMP release or inhibition of respective pattern recognition receptors might represent a promising therapeutic target not only to circumvent its detrimental effects and possible contribution in the subsequent development of PTOA (Rosenberg et al., 2017) but also to improve regenerative processes by CSPCs.
